Leader in Compassionate Care Infection Prevention Solutions, Covalon, to Participate in the Synova NICU Leadership Forum 2023 in Tucson, Arizona from March 19 to 23, 2023
Covalon Technologies Ltd., trading under the symbol CVALF, recently announced its participation in the Synova NICU Leadership Forum from March 19 to March 23, 2023, in Tucson, Arizona. The company will showcase its innovative infection prevention solutions at booth 106, emphasizing compassion in patient care, particularly for NICU and pediatric patients. Covalon's products, like the CovaClear IV and VALGuard, aim to improve patient outcomes while reducing stress for healthcare providers. Six of the top ten children's hospitals have adopted these solutions.
- None.
- None.
Visit booth 106 to learn how
"Here at
At this year's
At booth 106,
- CovaClear® IV – utilizes soft silicone adhesive technology to help protect patients from skin injuries, but does not incorporate antimicrobials, for use with patients who either don't require or cannot tolerate antimicrobials.
- VALGuard® - an FDA listed, transparent, environmental barrier designed to protect catheter hubs and line connections from external contaminants and gross contamination, including body fluids and other secretions. It incorporates a quick-release pull strip for fast access to infusion hubs and for easy removal.
- IV Clear® - the world's only dual-antimicrobial vascular access dressing that offers complete transparency at and around the insertion site for easy daily assessment. It also utilizes soft silicone adhesive technology to minimize skin injuries and preserve skin barrier functions, and incorporates safe amounts of antimicrobials, without sacrificing efficacy, to protect against chemical irritation.
- SurgiClear® - the world's only dual-antimicrobial clear postoperative dressing that provides full surgical site visibility, allowing for visual site inspection and thus eliminating the need for early and multiple dressing removals.
Dates:
Venue:
Website: https://www.synovaassociates.com/nicu-leadership-forum
For healthcare providers who are not able to attend the conference but are interested in learning more about
Neither the
This news release may contain forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "plan, "estimate", "expect", "intend", or variations of such words and phrases or state that certain actions, events, or results "may", "could", "would", "might", "will" or "will be taken", "occur", or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts, but instead represent management's expectations, estimates, and projections regarding future events. Forward-looking statements involve risks and uncertainties, including, but not limited to, the factors described in greater detail in the "Risks and Uncertainties" section of our management's discussion and analysis of financial condition and results of operations for the year ended
View original content to download multimedia:https://www.prnewswire.com/news-releases/leader-in-compassionate-care-infection-prevention-solutions-covalon-to-participate-in-the-synova-nicu-leadership-forum-2023-in-tucson-arizona-from-march-19-to-23-2023-301775530.html
SOURCE
FAQ
What is Covalon Technologies participating in March 2023?
Where is the Synova NICU Leadership Forum being held?
What products will Covalon showcase at the NICU Leadership Forum?
What does the CVALF stock symbolize?